You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 35 No. 5, May 1978 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Schizophrenic and Medical Inpatients as Informed Drug Consumers

David A. Soskis, MD

Arch Gen Psychiatry. 1978;35(5):645-647.


Abstract

• Twenty-five schizophrenic inpatients receiving antipsychotic medications were evaluated as informed and/or consenting drug consumers by means of a structured interview, in comparison with a matched group of medical inpatients receiving nonpsychotropic drugs. Medical patients were better informed about positive aspects of medication, such as name, dose, and relationship of drug treatment to a specific diagnosis. Schizophrenic patients, however, were significantly better informed about both side effects and risks. Although both groups felt that their medication had helped them, 93% of the medical patients but only 56% of the schizophrenic patients said they would take the medication if they had the choice. The fact that schizophrenic inpatients readily shared their reluctance to take medication with an interviewer may offer an avenue for detection and intervention to improve prospects for outpatient compliance.



Author Affiliations

From the Department of Psychiatry, Temple University School of Medicine, Philadelphia.


Footnotes

Accepted for publication Sept 15, 1977.

Reprint requests to Department of Psychiatry, 5-OPD, Temple University Health Sciences Center, 3401 N Broad St, Philadelphia, PA 19140 (Dr Soskis).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Emerging Empirical Evidence on the Ethics of Schizophrenia Research
Dunn et al.
Schizophr Bull 2006;32:47-68.
ABSTRACT | FULL TEXT  

Patient and Psychiatrist Ratings of Hypothetical Schizophrenia Research Protocols: Assessment of Harm Potential and Factors Influencing Participation Decisions
Roberts et al.
Am. J. Psychiatry 2002;159:573-584.
ABSTRACT | FULL TEXT  

Training Psychiatric Patients to Discuss Medication Issues: Effects on Patient Communication and Knowledge of Medications
Dow et al.
Behav Modif 1991;15:3-21.
ABSTRACT  

A Grounded Theory Study of the Informed Consent Process for Pharmacologic Research
Nusbaum and Chenitz
West J Nurs Res 1990;12:215-228.
 

Competency to Consent to Research: A Psychiatric Overview
Appelbaum and Roth
Arch Gen Psychiatry 1982;39:951-958.
ABSTRACT  

What We Do and Do Not Know About Informed Consent
Meisel and Roth
JAMA 1981;246:2473-2477.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1978 American Medical Association. All Rights Reserved.